Quick Answer
Cytek Biosciences, Inc. reported Shares Outstanding of 128.55 million shares for fiscal year 2025.
Cytek Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 128.55M | -0.5% |
| 2024 | 129.21M | -1.2% |
| 2023 | 130.71M | -3.4% |
| 2022 | 135.37M | +1.2% |
| 2021 | 133.75M | +328.1% |
| 2020 | 31.24M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 127.86M | -1.5% | +0.5% |
| June 30, 2025 | 127.19M | -3.3% | -0.3% |
| March 31, 2025 | 127.60M | -2.8% | -1.2% |
| December 31, 2024 | 129.21M | -1.2% | -0.4% |
| September 30, 2024 | 129.77M | -4.3% | -1.3% |
| June 30, 2024 | 131.51M | -3.5% | +0.2% |
| March 31, 2024 | 131.25M | -3.2% | +0.4% |
| December 31, 2023 | 130.71M | -3.4% | -3.6% |
- Cytek Biosciences, Inc. showed a decrease of -0.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Cytek Biosciences, Inc.’s shares outstanding has grown by 311.5% (from 31.24 million shares to 128.55 million shares).
- The most recent figure is from Cytek Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: